What does the ICH GCP Guideline aim to assure regarding trial participants?

• A. That the rights, safety, and well-being of trial participants are protected.
• B. That they are paid promptly.
• C. That they are allowed to withdraw without documentation.
• D. That they are tested only for safety.

Answer: (A)

The main idea is to protect people who take part in trials. ICH GCP sets up systems so participants’ rights, safety, and well-being are prioritized throughout the study. This includes ensuring informed consent so individuals understand what they’re agreeing to, potential risks, and expected benefits; independent ethics committee or IRB review to safeguard participants; ongoing safety monitoring and prompt handling of adverse events; and maintaining confidentiality of participant data. The aim is to balance scientific integrity with respect for the person volunteering, making sure participation is voluntary and can be withdrawn at any time with proper procedures.

Why the other options don’t fit: payment timing is not the central purpose of GCP and does not guarantee protection of rights or safety. withdrawal without documentation would undermine accountability and proper record-keeping that support participant protection. testing only for safety ignores the broader scope of clinical trials, which also evaluate the potential benefits and overall effectiveness, not just safety.